parkinson-s-disease

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most prevalent neurodegenerative disorders (ND) globally, disproportionately affecting the elderly population. Traditionally viewed as distinct diseases, AD is defined by symptoms of cognitive impairment and dementia with amyloid-β and tau protein pathologies, while PD is defined by motor symptoms and eventual dementia with α-synuc…

Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's disease (PD).

Parkinson's disease occurs when nerve cells in the brain that are responsible for producing dopamine, die or become impaired. Dopamine allows the body's muscles to move smoothly, and without it, a person slowly loses control of their movements. While the current treatment options for Parkinson's help to replenish a patient's dopamine levels, they are often only a short-term fix and can have sever…